ZISES SELIG

Director Zises Selig sold 30,000 shares at blended average $106.30 for $3.2M on Mar 18–19, reducing stake by 32.1%.

Director Zises Selig executed 12 separate sales totaling 30,000 shares for $3.2M over two days (March 18–19, 2026), reducing his position from 93,533 shares to 63,533 shares—a 32.1% reduction. The blended average sale price of $106.30 is slightly above the current price of $105.47, indicating the sales occurred near recent highs within the 52-week range of $71.30–$116.88. At the same-ticker level, Selig's five prior sales at ESQ (all on 2025-08-22) showed consistent positive 30-day returns (+3.5% to +3.8%) but negative 90-day returns (-3.8% to -4.1%), with a 5 of 5 well-timed rate at the 90-day mark. This large block sale, while executed at favorable prices relative to current levels, represents a substantial reduction in his ownership and warrants investor attention to any underlying material developments at the company or changes in his involvement with Esquire Financial.

Director ZISES SELIG sold 17,000 shares at blended $99.71 on 2025-08-22 for $1.7M; retains 79.0K shares

ZISES SELIG, a director at Esquire Financial Holdings, executed 12 separate sales totaling 17,000 shares for $1,695,095.60 at prices between $99.45 and $100.00, representing a -17.7% reduction from his 96,033 pre-transaction holdings. The current stock price of $100.48 sits -4.1% from the 52-week high of $104.78, and the stock has risen 12.4% over the past 90 days. Notably, his 5 prior sales at ESQ during 2025-04-29 all posted positive 90-day returns (ranging from 15.3% to 15.8%), meaning the stock rose after each sale—a 0% well-timed rate on those earlier trades. The stock's current valuation reflects a P/E of 18.47 against positive fundamentals ($11.9M net income, $858.0M market cap), leaving limited direct signal from price extremes alone.

Director Zises Selig sold 13.0K shares of ESQ for $1.1M at blended avg $84.09 on 2025-04-29, reducing stake by 12.4%

Zises Selig executed 7 separate sales totaling 13,000 shares for $1,093,139.00, reducing his holdings from 104,533 to 91,533 shares (-12.4% of pre-transaction stake). The sales occurred at prices ranging from $83.95 to $84.34, clustering near the blended average of $84.09. Against current price of $83.44 (down 6.6% from the 52-week high of $89.37), the sale occurred near a recent peak in a 30-day rally (+10.4%), positioning the insider's exit as preceding a subsequent decline. His prior five sales at ESQ (all on 2025-02-28) showed negative 30-day returns averaging -3.0%, but outcomes at the 90-day horizon remain unmeasurable. Cross-ticker, his 20 prior sells posted a 100.00% well-timed rate (90d return -7.7% on average), though this broader track record does not predict behavior at this specific ticker.

Director Selig sold 20,000 shares for $1.6M on 2025-02-28 at $77.59 blended average; stock now $73.98.

ZISES SELIG, a Director at Esquire Financial Holdings, Inc., filed 11 separate sales totaling 20,000 shares for $1,551,768.65, executed on 2025-02-28 at prices ranging from $76.70 to $78.32, with a blended average price of $77.59. This represents a 36.0% reduction in his holdings from 55,501 shares to 35,501 shares. The current stock price of $73.98 is down 17.2% from the transaction date's blended average, and the stock has declined 17.2% over the past 30 days and 6.2% over the past 90 days. His prior trades at ESQ show a consistent pattern: all 5 of his prior sells at this ticker have been well-timed at the 90-day mark, with negative returns ranging from -6.0% to -6.6% in the 30-day period and -7.3% to -7.8% in the 90-day period. The cross-ticker track record also reflects a 100.00% well-timed rate on sells, with an average 90-day return of -7.9%. Given the magnitude of the transaction and this insider's established pattern of well-timed sales at both the ticker-specific and cross-ticker levels, the market's subsequent 17.2% decline warrants investor attention as another data point in that pattern.